PepLabo Download

Mounjaro® and dental problems

Worries about teeth on weight and diabetes injections usually centre on two things: stomach acid from vomiting or reflux, and a drier mouth. Mounjaro® (tirzepatide) has a third angle that matters for dental care: it slows stomach emptying, which is why its label asks you to tell every clinician, dentists included, before sedation. This page sets out what the product information says, what the first large study of tirzepatide and gum outcomes in type 2 diabetes found, and what dental and diabetes sources suggest.

Published · Updated · Mounjaro®: side effects by symptom · Written by the PepLabo editorial team

What the product information covers

None of the US, European or Canadian documents lists a tooth or gum side effect [1][3][4]. Three listed effects can still reach the mouth.

Mounjaro® reactions relevant to the mouth (US placebo-controlled diabetes pool, 5 / 10 / 15 mg)
Listed effectMounjaro®PlaceboWhy it matters for teeth
Vomiting [1]5% / 5% / 9%2%Stomach acid on tooth surfaces [7]
Reflux disease [1]1.7% / 2.5% / 1.7%0.4%Acid reaching the mouth [7]
Delayed stomach emptying [1][3]Pharmacological effect; EU: uncommon side effect—Sedation planning [1][2]
Dental problems [1][3][4]Not listed——

The first large tirzepatide study on gums

A 2026 study used electronic health records from a global research network to compare adults with type 2 diabetes who started tirzepatide or a GLP-1 medicine between 2022 and 2025. After matching, each group had 97,993 people. Over one year, tirzepatide users had lower recorded rates of periodontitis (hazard ratio 0.70), tooth extraction (0.89), problems around dental implants (0.61), gum procedures (0.89) and mouth or jaw infections (0.70) [5].

Those numbers point away from harm, but the authors note that recorded event rates were low and records are not dental examinations. People who start one medicine rather than another may differ in ways that matching cannot remove. They call for prospective studies with proper dental assessments, and one author reported ties to several companies, including Lilly [5]. A 2026 narrative review similarly concludes that early evidence suggests incretin medicines may dampen gum inflammation, while effects on the jawbone remain uncertain [6].

How teeth could still be affected

  • Supported by the label: vomiting and reflux are more frequent than on placebo, especially while the dose is being raised [1].
  • Proposed by reviewers: reduced saliva combined with stomach acid from reflux or vomiting may make teeth more prone to erosion, though a direct link with these medicines has not been established [7]. Reviewers also link complaints popularly called “Ozempic teeth” to nausea, vomiting, belching and lower fluid intake [6].
  • General dental knowledge: bacteria turn sugars and starches into acid, and frequent snacking keeps that acid on the teeth for longer [11]. Some people manage nausea with small, frequent meals, which may mean more snacking; how this balances out has not been studied for tirzepatide.
  • Diabetes itself: NIH sources link diabetes with gum disease, dry mouth and thrush, a fungal infection, and say that poorly controlled blood sugar makes mouth problems more likely [8].

Other reasons teeth and gums suffer

The NIH names smoking or using tobacco as the most significant risk factor for gum disease, with older age, diabetes, genetics, stress and some illnesses and medicines also playing a part [9]. Hundreds of medicines reduce saliva, including some for blood pressure, depression and bladder control [10].

Gum disease begins with red, swollen or bleeding gums; later the gums can pull away, teeth can loosen and breath can stay bad [9]. Tooth decay often causes no symptoms until a cavity is large; then pain with sweet, hot or cold food and visible pits or dark spots are typical [11].

Dental visits while on Mounjaro®

Mounjaro® slows the stomach, so food can still be there hours after a meal. The US label reports rare cases of food or fluid entering the lungs in people on GLP-1 medicines having procedures under general anaesthesia or deep sedation, despite fasting, and asks patients to tell their providers before any planned procedure [1]. The Medication Guide says to tell all your healthcare providers [2], and Canada asks clinicians to weigh benefits and risks before such procedures [4]. That applies to sedation for dental surgery too. How to prepare is the dentist’s and prescriber’s decision; the label says the evidence is not yet enough to set rules on fasting or pausing the medicine [1].

If you also take insulin or a sulfonylurea, fasting before a procedure can affect blood sugar [1]. Mention all your diabetes medicines when you book.

Protecting your teeth

The Mounjaro® documents do not give dental advice. NIH and MedlinePlus sources suggest the following.

  • Brush at least twice a day and floss daily, and keep regular professional cleanings [8][11].
  • Tell your dentist you have diabetes and which medicines you use [8].
  • Use fluoride toothpaste; your dentist may also apply fluoride [11].
  • Eat sticky or sugary foods with meals rather than as snacks, and avoid constant sipping of sugary drinks [11].
  • For a dry mouth, sip water through the day and limit caffeine, tobacco and alcohol; sugarless gum can stimulate saliva [10].
  • If you smoke, your doctor or dentist can help you quit [8].

Mounjaro® is a registered trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.

When to get help

SignWho to contactHow fastSource
Dryness, soreness, white patches or a bad taste in the mouth, with diabetesYour dentistAt your next appointmentNIH [8]
Repeated vomiting or vomiting that does not stopYour healthcare provider right awayTodayMedication Guide [2]
Planned dental surgery or treatment under sedationTell your dentist and prescriber that you take Mounjaro®At your next appointmentUS label §5.9 [1]; Medication Guide [2]
Gums that bleed, look swollen or pull back, loose teeth or lasting bad breathYour dentistAt your next appointmentNIH [8][9]
Tooth pain, sensitivity or dark spots on teethYour dentistAt your next appointmentMedlinePlus [11]

Questions

Does Mounjaro rot your teeth?

Tooth decay is not a listed side effect [1][3][4]. Vomiting and reflux, which expose teeth to acid, are listed, and reviewers say this could contribute to erosion, without a proven link [1][7].

Is gum disease more likely on Mounjaro?

In a 2026 record study of adults with type 2 diabetes, tirzepatide users had lower recorded rates of periodontitis and tooth extraction than GLP-1 medicine users. It was observational, so it cannot prove the medicine protects gums [5].

Do I need to stop Mounjaro before dental sedation?

The US label says available data are not enough to recommend fasting changes or stopping the medicine, and asks you to tell your providers before the procedure so they can plan [1]. Follow your dentist’s and prescriber’s instructions.

Should I brush right after vomiting?

The Mounjaro® documents do not say. Ask your dentist how to care for your teeth after vomiting or reflux; frequent episodes are also worth telling your prescriber about [2].

I have diabetes and bleeding gums. Is it the medicine?

Bleeding gums are an early sign of gum disease, which is more common in diabetes and linked to blood sugar control [8][9]. See your dentist and mention all your medicines.

Can a dry mouth on Mounjaro cause cavities?

Dry mouth is not listed for Mounjaro® [1]. The NIH says dry mouth from any cause raises the risk of tooth decay, and diabetes itself can cause it [8][10].

Sources

Sources checked on

  1. MOUNJARO® (tirzepatide) Prescribing Information, Eli Lilly and Company Revised 08/2026. Sections 5.3, 5.9, 6.1 (Table 1 and gastrointestinal adverse reactions), 12.2 and 17; searched for dental terms.
  2. MOUNJARO® (tirzepatide) Medication Guide, Eli Lilly and Company Revised 08/2026.
  3. Mounjaro (tirzepatide): EPAR product information, European Medicines Agency Summary of product characteristics sections 4.4 and 4.8 (Table 1).
  4. MOUNJARO® Product Monograph (Canada), Eli Lilly Canada Inc. Authorized 2026-06-23. Section 7 (Perioperative Considerations) and Patient Medication Information.
  5. Tu CY, et al. Association of tirzepatide versus glucagon-like peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 diabetes: a global propensity score-matched cohort study. Diabetes Res Clin Pract. 2026;242:113573 Retrospective cohort (TriNetX); abstract. One author reports ties to several companies including Lilly.
  6. Bijoch J. Oral health implications of GLP-1 receptor agonists and other incretin-based therapies. J Clin Med. 2026;15(14):5358 Narrative review; abstract.
  7. Gilligan G, et al. Adverse oral and salivary effects associated with glucagon-like peptide-1 receptor agonists: clinical insights. J Oral Pathol Med. 2026 Narrative synthesis; abstract.
  8. Diabetes & Oral Health, National Institute of Dental and Craniofacial Research (NIH) Gum disease, dry mouth and thrush in diabetes; tips.
  9. Gum (Periodontal) Disease, National Institute of Dental and Craniofacial Research (NIH) Risk factors and symptoms.
  10. Dry Mouth, National Institute of Dental and Craniofacial Research (NIH) Causes, tooth decay risk and self-care.
  11. Tooth decay, MedlinePlus Medical Encyclopedia (U.S. National Library of Medicine) Causes, symptoms, prevention and when to contact a dentist.

Set up your lab tonight.

It takes a few minutes. Pep will be waiting.